Exactus Inc.,They changing the game for Point-of-Care technology. They are developing for commercialization Point-of-Care diagnostics for measuring proteolytic enzymes in the blood based on a novel, proprietary detection platform. We are designing products with the potential to deliver rapid, actionable information to physicians in order to provide improved treatment decisions for patients, better health outcomes and long term reduction in healthcare costs.